SCHEMBL28565602

SCHEMBL28565602

NC(=O)OC1CCc2nc(C3CC3)sc2C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 3/20 0.36
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HDAC9 Q9UKV0 1/20 0.33
MAPT P10636 3/20 0.33
LMNA P02545 2/20 0.33
HSD17B10 Q99714 2/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
DPP4 P27487 1/20 0.32
SCN9A Q15858 4/20 0.32
SCN3A Q9NY46 3/20 0.32
SCN5A Q14524 1/20 0.32
SCN4A P35499 2/20 0.31
THRB P10828 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28565598 1.00 PDK1 (0.36) PDK1NPC1RAB9ASMN1; SMN2HDAC9
SCHEMBL23306592 0.83 PDK1 (0.38) PDK1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL28549007 0.83 LMNA (0.46) MAPTLMNAHSD17B10POLBGAA
SCHEMBL23306633 0.83 LMNA (0.46) MAPTLMNAHSD17B10POLBGAA
SCHEMBL28560728 0.83 PDK1 (0.38) PDK1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL28549493 0.82 DPP4 (0.45) PDK1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL28549495 0.82 DPP4 (0.45) PDK1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL29145459 0.80 NPC1 (0.35) PDK1NPC1RAB9ASMN1; SMN2HDAC9
SCHEMBL28544943 0.77 PDK1 (0.34) PDK1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL28912404 0.68 SCN4A (0.48) GAASCN9ASCN3ASCN5ASCN4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112574191-A Isoxazole heterocyclic compound and application thereof 南京圣和药业股份有限公司 2021-03-30 CN disclosed